참고문헌
- Icli, F. and Arican, A. : Phase II study of cisplatin and dacarbazine for metastatic colorectal carcinoma resistant 5-fluorouracil. Oncology 5694, 297 (1999)
- Kessinger, M. A., Foley, J. F and Lemon, H. M. ; Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil. Cancer. Clin. Trials 2, 317 (1979)
- Saga, Y, Suzuki, M., Mizukami, H., Kohno, T., Takei, Y., Fukushima, M. and Ozawa, K. : Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells. Int. J. Cancer 106, 324 (2003) https://doi.org/10.1002/ijc.11221
- Yoshinare, K., Kubota, T., Watanabe, M., Wada, N., Nishibori, H., Hasegawa, H., Kitajima, M., Takechi, T. and Fukushima, M.. : Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: a study of 88 surgical specimens. Cancer Sci. 94, 633 (2003) https://doi.org/10.1111/j.1349-7006.2003.tb01495.x
- Meyers, M., Wagner, M. W., Hwang, H. S., Kinsella, T. J. and Boothman, D. A. : Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses. Cancer Res. 61, 5193 (2001)
- Violette, S., Poulain, L., Dussaulx, E., Pepin, D., Faussat, A. M., Chambaz, J., Lacorte, J. M., Staedel, C. and Lesuffleur, T. : Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int. J. Cancer 98, 498 (2002) https://doi.org/10.1002/ijc.10146
- Li, M. H., Ito, D., Sanada, M., Odani, T., Hatori, M., Iwase, M. and Nagumo, M. : Effect of 5-fluorouracil on G1 phase cell cycle regulation in oral cancer cell lines. Oral Oncol. 40, 63 (2004) https://doi.org/10.1016/S1368-8375(03)00136-2
- Wolfgang, M. Schmidt and Maria Kalipciyan : Dissecting progressive stages of 5-Fluorouracil resistance in vitro using RNA expression profiling. Int. J. Cancer 112, 200 (2004) https://doi.org/10.1002/ijc.20401
- Nakamura, N. and Takenaga, K. : Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin. Exp. Metastasis 16, 471 (1998)
- Murai, M., Toyota, M., Suzuki, H., Satoh, A., Sasaki, Y., Akino, K., Ueno, M., Takahashi, F., Kusano, M., Mita, H., Yanagihara, K., Endo, T., Hinoda, Y., Tokino, T. and Irnai, K. : Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer. Clincal Cancer Res. 11, 1021 (2005)
- Kopelovich, L., Crowell, J. A. and Fay, J. R. : The epigenome as a target for cancer chemoprevention. J. Natl. Cancer Inst. 95, 1747 (2003) https://doi.org/10.1093/jnci/dig109
- Zhu, W. G. and Otterson, G. A. : The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells. Curr. Med. Chem. Anti-Canc. Agents 3, 187 (2003) https://doi.org/10.2174/1568011033482440
- Rice, J. C. and Allis, C. D. : Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol. 3, 263 (2001) https://doi.org/10.1016/0955-0674(91)90158-U
- de Angelis, P. M., Fjell, B., Kravik, K. L., Haug, T., Tunheim, S. H., Reichelt, W., Beigi, M., Clausen, O. P., Galteland, E. and Stokke, T. : Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. Int. J. Oncol. 24, 1279 (2004)
- Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D. and Baylin, S. B. : Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93, 9821 (1996)
-
Esteller, M., Tortola, S., Toyota, M., Capella, G., Peinado, M. A., Baylin, S. B. and Herman, J. G. : Hypermethylationassociated inactivation of
$p14^{ARF}$ is in- depepdent of$p16^{INK4a}$ methylation and p53 mutational status. Cancer Res. 50, 129 (2000) - Chou, T.-C. and Talalay, P. : Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27 (1984) https://doi.org/10.1016/0065-2571(84)90007-4
- Longley, D. B., Harkin, D. P. and Johnston, P. G. : 5-fluorouracil: mechanism of action and clinical strategies. Nature 3, 330 (2003) https://doi.org/10.1038/nmat1116
- Kanda, T., Tada, M., Imazeki, F., Yokosuka, O., Nagao, K. and Saisho, H. : 5-aza-2'-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines. Oncol. Rep. 14, 975 (2005)
- Momparler, R. L. : Pharmacology of 5-aza-2'-deoxycytidine (decitabine) Semin. Hematol. 42, 9 (2005)
- Xiao, J. J., Foraker, A. B., Swaan, P. W., Liu, S., Huang, Y., Dai, Z., Chen, J., Sadee, W., Byrd, J., Marcucci, G. and Chan, K K. : Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1. J. Pharmacol. Exp. Ther. 313, 268 (2005) https://doi.org/10.1124/jpet.104.072033
- Murata, M., Towatari, M., Kosugi, H., Tanimoto, M., Ueda, R., Saito, H. and Naoe, T. : Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells. Jpn. J. Cancer Res. 91, 1154 (2000) https://doi.org/10.1111/j.1349-7006.2000.tb00899.x
- Nakumura, T., Sakaeda, T., Ohmoto, N., Moriya, Y, Komoto, C., Shirakawa, T., Gotoh, A., Matsuo, M. and Okmura, K. : Gene expression profiles of ABC transporters and cytochrome P450 3A in Caco-2 and human colorectal cancer cell lines. Pharm. Res. 20, 324 (2003) https://doi.org/10.1023/A:1022251910820
- Primeau, M., Gagnon, J. and Momparler, R. L. : Synegistic antineoplastic action of DNA methylation inhibitor 5-aza-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells. Int. J. Cancer 103, 177 (2003) https://doi.org/10.1002/ijc.10789
- Gagnon, J., Shake, S., Primeau, M., Hurtubise, A. and Momparler, R. L. : Interaction of 5-aza-2'-deoxycytidine and depsipeptide on antineoplastic activity and activation of 14-3-3sigma, E-cadherin and tissue inhibitor of metalloproteinase 3 expression in human breast carcinoma cells. Anticancer Drugs 14, 193 (2003) https://doi.org/10.1097/00001813-200303000-00002
- Arnold, C. N., Goel, A. and Boland, C. R. : Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorourcil in colorectal cancer cell lines. Int. J. Cancer 106, 66 (2003) https://doi.org/10.1002/ijc.11176